Financial Statements — HIPO
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 0.24 | 0.28 | 0.25 | 0.20 | 0.14 | 0.19 | 0.22 | 0.23 | 0.20 | 0.19 | 0.35 | 0.28 | 0.34 | 0.78 | 0.00 | 0.00 |
| Total Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 |
| Total Assets | 2.32 | 2.06 | 1.87 | 1.71 | 1.54 | 1.55 | 1.50 | 1.65 | 1.68 | 1.60 | 1.63 | 1.63 | 1.67 | 1.66 | 0.23 | 0.23 |
| Total Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 |
| Total Liabilities | 1.85 | 1.61 | 1.45 | 1.37 | 1.21 | 1.22 | 1.14 | 1.24 | 1.23 | 1.06 | 0.99 | 0.88 | 0.87 | 0.75 | 0.03 | 0.02 |
| Retained Earnings | (1.20) | (1.21) | (1.22) | (1.32) | (1.32) | (1.32) | (1.27) | (1.19) | (1.14) | (1.03) | (0.90) | (0.77) | (0.70) | (0.57) | (0.01) | -0.00 |
| Total Stockholder Equity* | 0.47 | 0.45 | 0.42 | 0.33 | 0.32 | 0.33 | 0.35 | 0.41 | 0.45 | 0.54 | 0.64 | 0.75 | 0.81 | 0.90 | 0.01 | 0.01 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Net Premiums Earned | 118.70 | 98.90 | 99.10 | 99.70 | 94.00 | 87.30 | 70.60 | 60.50 | 38.50 | 32.90 | 22.30 | 13.80 | 11.60 | 10.70 | 11.20 | 9.00 | 9.00 | 10.90 | -- | -- |
| Net Investment Income | 6.60 | 6.70 | 6.60 | 7.30 | 5.70 | 5.80 | 6.20 | 5.90 | 6.60 | 5.70 | 5.40 | 5.40 | 5.00 | 2.50 | 1.10 | 0.40 | 0.10 | 0.10 | -- | -- |
| Total Revenue | 144.70 | 121.50 | 120.40 | 120.60 | 117.30 | 110.30 | 95.50 | 85.10 | 64.50 | 57.70 | 47.70 | 39.80 | 35.80 | 30.70 | 28.70 | 24.50 | 32.10 | 21.30 | -- | -- |
| Total Benefits & Expenses | 133.70 | 114.30 | 113.60 | 22.50 | 113.30 | 155.90 | 100.70 | 118.00 | 103.60 | 108.30 | 152.70 | 107.60 | 95.80 | 157.90 | 100.40 | 90.80 | 91.10 | 51.10 | -- | -- |
| Operating Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | (0.56) | (1.46) |
| Tax Provision | 0.90 | 0.10 | 0.80 | 0.00 | 0.10 | (0.20) | 0.00 | 0.20 | 0.30 | (0.30) | 0.20 | 0.30 | 0.50 | 0.30 | 0.30 | 0.20 | 0.30 | 0.10 | -- | -- |
| Net Income | 10.10 | 7.10 | 6.00 | 98.10 | 1.30 | (47.70) | (8.50) | (35.70) | (42.40) | (53.10) | (107.80) | (69.80) | (63.10) | (129.20) | (73.50) | (67.60) | (335.41) | (30.90) | (2.63) | (2.46) |
| Diluted EPS | 0.38 | 0.27 | 0.31 | 3.77 | 0.05 | (1.91) | (0.34) | (1.47) | (1.72) | (2.24) | (4.61) | (3.01) | (8.75) | (5.66) | (0.13) | (0.12) | 0.41 | (0.08) | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Operating Cash Flow | 43.10 | 8.50 | 3.20 | 16.90 | 24.70 | (35.60) | (10.60) | 17.70 | (48.50) | 1.10 | (9.30) | (35.70) | (30.10) | (43.00) | (29.80) | (58.60) | 2.60 | (126.50) | (0.19) | (0.41) |
| Capital Expenditures | 0.10 | 0.10 | 0.00 | 0.10 | (0.10) | 0.10 | 0.10 | 0.10 | 0.40 | 0.20 | 29.00 | 0.00 | 0.10 | 1.80 | 0.60 | 2.40 | 0.70 | 0.10 | -- | -- |
| Free Cash Flow* | 43.00 | 8.40 | 3.20 | 16.80 | 24.80 | (35.70) | (10.70) | 17.60 | (48.90) | 0.90 | (38.30) | (35.70) | (30.20) | (44.80) | (30.40) | (61.00) | 1.90 | (126.60) | -- | -- |
| Investing Cash Flow | (77.20) | 42.50 | (25.70) | 47.40 | (21.90) | (11.00) | (28.10) | 58.50 | (22.00) | 30.80 | 35.00 | 13.80 | (115.20) | 112.50 | (25.00) | (378.20) | (7.10) | (22.97) | 0.07 | -- |
| Financing Cash Flow | 0.90 | 3.70 | 0.40 | (17.90) | 42.80 | (6.00) | (4.40) | (8.00) | (3.80) | (0.90) | (8.00) | (1.90) | (3.10) | (1.10) | (2.30) | (0.30) | 0.40 | 480.40 | -- | -- |
* Derived from reported values
